Dr. Gregory Biedermann, MD
Claim this profileUniversity of Missouri - Ellis Fischel
Studies Brain Tumor
Studies Cancer
10 reported clinical trials
33 drugs studied
Area of expertise
1Brain Tumor
IDH positive
1p/19q co-deletion positive
1p/19q loss positive
2Cancer
p16 positive
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Gregory Biedermann, MD is currently running
Chemotherapy + Reduced-Dose Radiation
for Throat Cancer
This trial will explore giving standard dose chemotherapy and radiation therapy to sites of disease including all lymph nodes involved with HPV-positive oropharyngeal cancer, but administer lower doses of radiation therapy to the lymph nodes that are not known to be involved with cancer. By doing so, it is hypothesized that there will be equally good long term loco-regional and distant disease control but will reduced long term treatment side effects and improved quality of life in persons living well beyond their cancer treatment.
Recruiting1 award Phase 226 criteria
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
More about Gregory Biedermann, MD
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Gregory Biedermann, MD has experience with
- Radiation Therapy
- Degarelix
- Histrelin
- Bicalutamide
- Leuprolide
- Triptorelin
Breakdown of trials Gregory Biedermann, MD has run
Brain Tumor
Cancer
Breast Cancer
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gregory Biedermann, MD specialize in?
Gregory Biedermann, MD focuses on Brain Tumor and Cancer. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are 1p/19q co-deletion positive.
Is Gregory Biedermann, MD currently recruiting for clinical trials?
Yes, Gregory Biedermann, MD is currently recruiting for 7 clinical trials in Columbia Missouri. If you're interested in participating, you should apply.
Are there any treatments that Gregory Biedermann, MD has studied deeply?
Yes, Gregory Biedermann, MD has studied treatments such as Radiation Therapy, Degarelix, Histrelin.
What is the best way to schedule an appointment with Gregory Biedermann, MD?
Apply for one of the trials that Gregory Biedermann, MD is conducting.
What is the office address of Gregory Biedermann, MD?
The office of Gregory Biedermann, MD is located at: University of Missouri - Ellis Fischel, Columbia, Missouri 65212 United States. This is the address for their practice at the University of Missouri - Ellis Fischel.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.